Resolvin E1 and protectin D1 activate inflammation-resolution programmes

By J. Schwab, Chia Nan, M. Arita, C. Serhan. Nature, 2007

1,213 citations recorded by the source corpus.

Subfields: Epidemiology, Immunology, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/a1e5bae116628464561126a60a4f21319242df6a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. B. Levy
2. D. Prockop
3. C. Serhan
4. P. Delafontaine
5. Kevin J. Tracey
6. C. Deutschman

In Immunology

1. C. Serhan
2. B. Levy
3. D. Gilroy
4. C. Deutschman
5. N. Borregaard
6. Paul Martin
7. DM Mosser
8. X. Zhang

In Nutrition and Dietetics

1. B. Levy
2. D. Gilroy
3. C. Buckley
4. N. Borregaard
5. S. Leng
6. H. Aukema
7. Md Monirujjaman
8. M. Gabbs

Citations in the corpus

• Neutrophils, from marrow to microbes. (2010, background): “IL-17A is an important stimulus for G-CSF production (Schwarzenberger et al., 2000).”
• Wound repair at a glance (2009, background): “…include sequestration of proinflammatory chemokines by non-functional ‘decoy’ receptors on the inflammatory cells themselves (D’Amico et al., 2000) and production of endogenous anti-inflammatory molecules such as resolvin E (Schwab et al., 2007) and annexin I (Perretti and Gavins, 2003).”
• Resolvins RvE1 and RvD1Attenuate Inflammatory Pain via Central and Peripheral Actions (2010, neutral): “For example, inhibitors of COX and lipoxygenases disrupt resolution, because these enzymes are also required for the biosynthesis of proresolution mediator”
• Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. (2015, background): “RvE1 Reduces dermal inflammation, peritonitis, dendritic cell migration, and IL-12 production in an inflammatory mouse model (305) Reduces total leukocytes and PMN infiltration in murine peritonitis (306) Reduces hepatic fibrosis in murine model of infection (307) Promotes phagocyte removal during a”
• Repertoire of microglial and macrophage responses after spinal cord injury (2011, background): “In a zymosan-initiated peritonitis model of inflammation, a class of non-phlogistic (anti-inflammatory) monocytes recruited by resolvin E1 (RvE1) and protectin D1 (PD1) leads to phagocytosis of polymorphonuclear leukocytes (PMNs) and to the active resolution of inflammatio”
• Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties (2010, methodology): “To test the effects of spheroid hMSCs on inflammation in vivo, a mouse model of zymosan-induced peritonitis was used (26).”
• Macrophage activation by endogenous danger signals (2008, background): “Resolvins, along with lipoxins derived from arachidonic acid, can contribute to resolution phase of inflammation by inhibiting PMN chemotaxis and by promoting the uptake of apoptotic cells by macrophages [113,114].”
• Sepsis: current dogma and new perspectives. (2014, background): “feedback from the nervous system that suppresses the release of inflammatory mediators and stimulates the release of resolvins (Nathan and Ding, 2010; Schwab et al., 2007; Medzhitov, 2010; Andersson and Tracey, 2012a).”
• Pro-Resolving lipid mediators and Mechanisms in the resolution of acute inflammation (2014, background): “P A A uthor M anuscript (Schwab et al., 2007; Serhan et al., 2002).”